Detalles de la búsqueda
1.
Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels.
Mol Pharm
; 18(11): 4198-4209, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668379
2.
An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis.
Acta Pharm Sin B
; 14(6): 2669-2684, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38828156
3.
Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery.
Pharmaceutics
; 15(2)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36839869
4.
Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design.
Eur J Pharm Sci
; 124: 319-327, 2018 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194980
5.
Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
Eur J Pharm Biopharm
; 120: 116-125, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28887098
6.
A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
J Pharm Sci
; 103(2): 527-38, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375069
Resultados
1 -
6
de 6
1
Próxima >
>>